TY  - GEN
AU  - Emadi,Ashkan
AU  - Faramand,Rawan
AU  - Carter-Cooper,Brandon
AU  - Tolu,Seda
AU  - Ford,Laurie A
AU  - Lapidus,Rena G
AU  - Wetzler,Meir
AU  - Wang,Eunice S
AU  - Etemadi,Arash
AU  - Griffiths,Elizabeth A
TI  - Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia
SN  - 1096-8652
PY  - 2015///0623
KW  - Age Factors
KW  - Aged
KW  - Antimetabolites, Antineoplastic
KW  - therapeutic use
KW  - Azacitidine
KW  - analogs & derivatives
KW  - DNA Modification Methylases
KW  - antagonists & inhibitors
KW  - Decitabine
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Isocitrate Dehydrogenase
KW  - genetics
KW  - Leukemia, Myeloid, Acute
KW  - diagnosis
KW  - Male
KW  - Mutation
KW  - Odds Ratio
KW  - Prognosis
KW  - Remission Induction
KW  - Retrospective Studies
KW  - Sex Factors
N1  - Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ajh.23965
ER  -